Annual Cash & Cash Equivalents
$148.64 M
+$91.40 M+159.67%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual cash & cash equivalents is $148.64 million, with the most recent change of +$91.40 million (+159.67%) on December 31, 2023.
- During the last 3 years, XENE annual cash & cash equivalents has risen by +$103.63 million (+230.25%).
- XENE annual cash & cash equivalents is now -15.39% below its all-time high of $175.69 million, reached on December 31, 2021.
Performance
XENE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$87.62 M
-$49.11 M-35.92%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly cash and cash equivalents is $87.62 million, with the most recent change of -$49.11 million (-35.92%) on September 30, 2024.
- Over the past year, XENE quarterly cash and cash equivalents has dropped by -$49.11 million (-35.92%).
- XENE quarterly cash and cash equivalents is now -76.32% below its all-time high of $369.99 million, reached on June 30, 2022.
Performance
XENE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XENE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +159.7% | -35.9% |
| 3 y3 years | +230.3% | +35.7% |
| 5 y5 years | +119.4% | +35.7% |
XENE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.4% | +159.7% | -76.3% | +53.1% |
| 5 y | 5-year | -15.4% | +500.5% | -76.3% | +480.3% |
| alltime | all time | -15.4% | +769.5% | -76.3% | +496.6% |
Xenon Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $87.62 M(-35.9%) |
| Jun 2024 | - | $136.73 M(+132.2%) |
| Mar 2024 | - | $58.90 M(-60.4%) |
| Dec 2023 | $148.64 M(+159.7%) | $148.64 M(+49.3%) |
| Sep 2023 | - | $99.57 M(+54.3%) |
| Jun 2023 | - | $64.55 M(-7.1%) |
| Mar 2023 | - | $69.51 M(+21.4%) |
| Dec 2022 | $57.24 M(-67.4%) | $57.24 M(-44.7%) |
| Sep 2022 | - | $103.49 M(-72.0%) |
| Jun 2022 | - | $369.99 M(+217.5%) |
| Mar 2022 | - | $116.54 M(-33.7%) |
| Dec 2021 | $175.69 M(+290.3%) | $175.69 M(+100.1%) |
| Sep 2021 | - | $87.81 M(+5.9%) |
| Jun 2021 | - | $82.93 M(-5.7%) |
| Mar 2021 | - | $87.98 M(+95.5%) |
| Dec 2020 | $45.01 M(+81.8%) | $45.01 M(+198.1%) |
| Sep 2020 | - | $15.10 M(-65.8%) |
| Jun 2020 | - | $44.20 M(-27.0%) |
| Mar 2020 | - | $60.51 M(+144.4%) |
| Dec 2019 | $24.75 M | $24.75 M(-34.3%) |
| Sep 2019 | - | $37.67 M(+1.6%) |
| Jun 2019 | - | $37.08 M(-28.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $52.18 M(-23.0%) |
| Dec 2018 | $67.75 M(+230.7%) | $67.75 M(-23.0%) |
| Sep 2018 | - | $87.96 M(+85.4%) |
| Jun 2018 | - | $47.44 M(+175.8%) |
| Mar 2018 | - | $17.20 M(-16.0%) |
| Dec 2017 | $20.49 M(+19.8%) | $20.49 M(+39.5%) |
| Sep 2017 | - | $14.69 M(-36.4%) |
| Jun 2017 | - | $23.09 M(+14.5%) |
| Mar 2017 | - | $20.16 M(+17.9%) |
| Dec 2016 | $17.09 M(-70.9%) | $17.09 M(-68.4%) |
| Sep 2016 | - | $54.13 M(+53.7%) |
| Jun 2016 | - | $35.21 M(-37.2%) |
| Mar 2016 | - | $56.06 M(-4.4%) |
| Dec 2015 | $58.65 M(-18.6%) | $58.65 M(-10.4%) |
| Sep 2015 | - | $65.47 M(+1.7%) |
| Jun 2015 | - | $64.35 M(-2.4%) |
| Mar 2015 | - | $65.92 M(-8.5%) |
| Dec 2014 | $72.03 M(+89.8%) | $72.03 M(+113.5%) |
| Sep 2014 | - | $33.73 M(-3.9%) |
| Jun 2014 | - | $35.09 M(-7.5%) |
| Dec 2013 | $37.95 M(-36.9%) | $37.95 M |
| Dec 2012 | $60.16 M | - |
FAQ
- What is Xenon Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Xenon Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Xenon Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of XENE is $148.64 M
What is the all time high annual cash & cash equivalents for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual cash & cash equivalents is $175.69 M
What is Xenon Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, XENE annual cash & cash equivalents has changed by +$91.40 M (+159.67%)
What is Xenon Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of XENE is $87.62 M
What is the all time high quarterly cash and cash equivalents for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly cash and cash equivalents is $369.99 M
What is Xenon Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, XENE quarterly cash and cash equivalents has changed by -$49.11 M (-35.92%)